Clinical Trial Update: Ketamine Treatment for Pediatric-Refractory Obsessive-Compulsive Disorder (OCD) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on ketamine for pediatric-refractory obsessive-compulsive disorder with completed Phase 1 and Phase 2, results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Obsessive-Compulsive Disorder | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-08-17